SPINAL MUSCULAR ATROPHY TYPE 2
Clinical trials for SPINAL MUSCULAR ATROPHY TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new SPINAL MUSCULAR ATROPHY TYPE 2 trials appear
Sign up with your email to follow new studies for SPINAL MUSCULAR ATROPHY TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hopes to boost muscle power in babies with SMA
Disease control Recruiting nowThis study tests a drug called apitegromab in children under 2 years old who have spinal muscular atrophy (SMA), a genetic condition that causes muscle weakness. The drug works by blocking a protein that limits muscle growth. Researchers want to see if adding apitegromab to stand…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 2
Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New fabric brace could give arm strength back to patients with muscle diseases
Symptom relief Recruiting nowThis study tests a special fabric shoulder brace designed to mimic muscle support for people with neuromuscular disorders like muscular dystrophy, SMA, and ALS. About 30 participants will wear the brace and perform arm tasks to see if it improves movement, strength, and daily fun…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 2
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC